Trial Profile

Trial of Sinovac's measles mumps and rubella virus vaccine in China

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 25 Mar 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Measles mumps and rubella vaccine Sinovac Biotech (Primary)
Indications Measles; Mumps; Rubella
Focus Adverse reactions

Most Recent Events

25 Mar 2015 New trial record
17 Mar 2015 The clinical trial application for this study of measles mumps and rubella virus vaccine was filed with the China Food and Drug Administration in April 2011, and Sinovac obtained the clinical trial license in December 2014, according to a company media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com